Filing Details

Accession Number:
0001209191-15-015142
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-18 14:03:13
Reporting Period:
2015-02-13
Filing Date:
2015-02-18
Accepted Time:
2015-02-18 14:03:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1044378 Biocept Inc BIOC Services-Medical Laboratories (8071) 330757995
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591849 W. Michael Nall C/O Biocept, Inc.
5810 Nancy Ridge Drive # 150
San Diego CA 92121
Ceo & President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-02-13 12,000 $1.25 12,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to Purchase Common Stock Acquisiton 2015-02-13 12,000 $0.00 12,000 $1.56
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,000 2015-02-13 2020-02-13 No 4 P Direct
Footnotes
  1. Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.25 per unit.